INS and diabetes mellitus: Perhaps most importantly for the prostate cancer patient with diabetes or some degree of insulin insensitivity, muscle contraction-stimulated release of AMPK and the mitigation of serum glucose levels via cellular influx are independent of insulin sensitivity [53].